Macular Degeneration Research Program: Standard Awards
Grant amount: Up to US $160,000
Next deadline: Oct 16, 2018 8:59pm PDT (Full proposal)
Later deadlines: Jun 26, 2019 8:59pm PDT (Letter of inquiry)
Applicant type: College / University Nonprofit
Funding uses: Clinical Biomedical
Location of project: Anywhere in the world
Location of residency: Anywhere in the worldView website Save Need help writing this grant?
Macular Degeneration Research Program
Since 1999, Macular Degeneration Research (MDR) has awarded more than $21.5 million to support research into the causes and potential prevention strategies and treatments of macular degeneration disease. MDR is currently supporting 40 biomedical researcher projects.
Age-related macular degeneration (AMD) is an irreversible destruction of the central area of the retina, called the macula. The retina is the light sensitive layer of tissue that lines the back of the eye and transmits visual information via the optic nerve to the brain. Macular degeneration leads to loss of the sharp, fine-detail, “straight-ahead” vision required for reading, driving, recognizing faces, and seeing the world in color, for example.
Macular degeneration is a leading cause of vision loss and irreversible blindness in Americans age 60 years and older and advanced AMD is a leading cause of irreversible blindness and visual impairment in the world. As many as 11 million Americans have some form of macular degeneration, including both early and later stages of the wet and dry forms. This number is expected to double by 2050.
The standard award provides significant funding for researchers who have already generated some amount of preliminary data, but are often required to demonstrate additional, significant progress before they can apply to governmental or industrial funding agencies.
You can learn more about this opportunity by visiting the funder's website.
- BrightFocus will fund grants for research at non-profit organizations or institutions only.
- Each Grantee Institution must submit evidence of its tax-exempt status to BrightFocus prior to the distribution of any Grant including but not limited to, a tax determination from the Internal Revenue Service.
- For foreign institutions: Each Grantee Institution must submit evidence of its tax-exempt status to BrightFocus prior to the distribution of any Grant, including but not limited to, a determination of tax-exempt or nonprofit status from their home country of origin.
- All Grants must be used exclusively for research and research equipment not for overhead, capital expenditures, administrative costs or other peripheral costs, except where BrightFocus, in its discretion, may make an exception for costs associated with the publication of the results of the BrightFocus sponsored research in academic journals, or for costs associated with participation in academic conferences.
- The BrightFocus Grant may pay for all or a portion of the salary of the Principal Investigator provided the salary request is justified in the Grant application and is in accordance with rules specified in the application guidelines.
About this funder:
Find more grants like this
Find more grants like the Macular Degeneration Research Program: Standard Awards by joining Instrumentl.
We help nonprofits and academics find more grants and take control of their grants process with a refreshingly intuitive online platform.